Comparative lymphatic, ocular, and metabolic phenotypes of FOXC2 haploinsufficient and AP2-FOXC2 transgenic mice

Lymphology

Volumn 39, Issue 2, 2006, Pages 84-94

  Noon, A ^a   Hunter, R J ^a   Witte, M H ^a   Kriederman, B ^a   Bernas, M ^a   Rennels, M ^a   Percy, D ^c   Enerback S ^d   Erickson, Robert P ^a,b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF GUELPH   (Canada)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Adipocyte; FOXC2; Foxc2; Haploinsufficient; Lymphatic hyperplasia; Lymphedema Distichiasis; Ocular; Transgenic

Indexed keywords

EVANS BLUE;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AP2 FOXC2 GENE; ARTICLE; BODY FAT DISTRIBUTION; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; DISSECTING MICROSCOPE; EYE DISEASE; GENE; GENE DISRUPTION; GENE MUTATION; GENE OVEREXPRESSION; HAPLOIDY; HAPLOINSUFFICIENCY; HETEROZYGOTE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; LIPID METABOLISM; LYMPH NODE; LYMPHATIC SYSTEM; LYMPHEDEMA DISTICHIASIS; MICROSCOPE; MICROSCOPY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; TRANSGENIC MOUSE; WHITE ADIPOSE TISSUE;

ADIPOCYTES; ANIMALS; DISEASE MODELS, ANIMAL; EYELASHES; FATTY ACID-BINDING PROTEINS; FATTY ACIDS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GLUCOSE; HETEROZYGOTE; HUMANS; IMMUNOENZYME TECHNIQUES; INSULIN; LYMPHATIC ABNORMALITIES; LYMPHEDEMA; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC;

EID: 33745997336     PISSN: 00247766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Carlsson, P, M Mahlapuu: Forkhead transcription factors: Key players in development and metabolism. Devel. Biol. 250 (2002), 1-23.
2. Fang, J, SL Dagenais, RP Erickson, et al: Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. Am. J. Hum. Genet. 67 (2000), 1382-1388.
3. Finegold, DN, MA Kimak, EC Lawrence, et al: Truncating mutations in FOXC2 cause multiple lymphedema syndromes. Hum. Mol. Genet. 10 (2001), 1185-1189.
4. Erickson, RP, SL Dagenais, MS Caulder, et al: Clinical heterogeneity in lymphoedema-distichiasis with FOXC2 truncating mutations. J. Med. Genet. 38 (2001), 761-766.
5. Brice, G, S Mansour, R Bell, et al: Analysis of the phenotypic abnormalities in lymphoedema-distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24. J. Med. Genet. 39 (2002), 478-483.
6. Bahuau, M, C Houdayer, M Tredano, et al: FOXC2 truncating mutation in distichiasis, lymphedema, and cleft palate. Clin. Genet. 62 (2002), 470-473.
7. Sholto-Douglas-Vernon, C, R Bell, G Brice, et al: Lymphoedema- distichiasis and FOXC2: Unreported mutations, de novo mutation estimate, families without coding mutations. Hum. Genet. 117 (2005), 238-242.
8. Saleem, RA, S Banerjee-Basu, FB Berry, et al: Analyses of the effects that disease-causing missense mutations have on the structure and function of the winged-helix protein FOXC1. Am. J. Hum. Genet. 68 (2001), 627-641.
9. Iida, K, H Koseki, H Kakinuma, et al: Essential roles of the winged helix transcription factor MFH-1 in aortic arch patterning and skeletogenesis. Development 124 (1997), 4627-4638.
10. Kume, T, KY Deng, V Winfrey, et al: The forkhead/winged helix gene Mf1 is disrupted in the pleiotropic mouse mutation congenital hydrocephalus. Cell 93 (1998), 985-996.
11. Dagenais, SL, RL Hartsough, RP Erickson, et al: Foxc2 is expressed in developing lymphatic vessels and other tissues associated with lymphedema-distichiasis syndrome. Gene Expr. Patterns 4 (2004), 611-619.
12. Petrova, TV, T Karpanene, C Norrmen, et al: Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat. Med. 10 (2004), 974-981.
13. Cederberg, A, LM Gronning, B Ahren, et al: FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance. Cell 106 (2001), 563-573.
14. Kriederman, BM, TL Myloyde, MH Witte, et al: FOXC2 haploinsufficient mice are a model for human autosomal dominant lymphedema-distichiasis syndrome. Hum. Mol. Genet. 12 (2003), 1179-1185.
15. Ridderstrale, M, E Carlsson, M Klammemark, et al: FOXC2 mRNA expression and a 5' untranslated region polymorphism of the gene are associated with insulin resistance. Diabetes 51 (2002), 3554-3560.
16. Di Gregorio, GB, R Westergren, S Enerback, et al: Expression of FOXC2 in adipose and muscle and its association with whole body insulin sensitivity. Am. J. Physiol. Endocrinol. Metab. 287 (2004), E799-E803.
17. Kovacs, P, A Lehn-Stefan, M Stumvoll, et al: Genetic variation in the human winged helix/forkhead transcription factor gene FOXC2 in Pima Indians. Diabetes 52 (2003), 1292-1295.
18. Osawa, H, H Onuma, A Murakami, et al: Systematic search for single nucleotide polymorphisms in the FOXC2 gene. Diabetes 52 (2003), 562-567.
19. Yang, X, S Enerback, U Smith: Reduced expression of FOXC2 and brown adipogenic genes in human subjects with insulin resistance. Obes. Res. 11 (2003), 1182-1191.
20. Yanagisawa, K, L Hingstrup Larsun, G Andersen, et al: The FOXC2-512C>T variant is associated with hypertriglyceridaemia and increased serum C-peptide in Danish Caucasian glucose-tolerant subjects. Diabetologia 46 (2003), 1576-1580.
21. Carlsson, E, P Almgren, J Hoffstedt, et al: The FOXC2 C-512T polymorphism is associated with obesity and dyslipidemia. Obes. Res. 12 (2004), 1738-1743.
22. Carlsson, E, L Groop, M Ridderstrale: Role of the FOXC2-512C>T polymorphism in type 2 diabetes: Possible association with the dysmetabolic syndrome. Int. J. Obes. (Lond). 29 (2005), 268-274.
23. Harvey, NL, RS Srinivasan, ME Dillard, et al: Lymphatic vascular defects promoted by Prox1 haploinsufficiency cause adult-onset obesity. Nat. Genet. 37 (2005), 1072-1081.
24. Spiegelman, BM, M Frank, H Green: Molecular cloning of mRNA from 3T3 adipocytes. Regulation of mRNA content for glycerophosphate dehydrogenase and other differentiation-dependent proteins during adipocyte development. J. Biol. Chem. 258 (1983), 10083-10089.
25. Herrera, R, HS Ro, GS Robinson, et al: A direct role for C/EBP and the AP-I-binding site in gene expression linked to adipocyte differentiation. Mol. Cell Biol. 9 (1989), 5331-5339.
26. Ross, SR, RA Graves, A Greenstein, et al: A fat-specific enhancer is the primary determinant of gene expression for adipocyte P2 in vivo. Proc. Natl. Acad. Sci. USA 87 (1990), 9590-9594.
27. Smith, RS, A Zabaleta, T Kume, et al: Haploinsufficiency of the transcription factors FOXC1 and FOXC2 results in aberrant ocular development. Hum. Mol. Genet. 9 (2000), 1021-1032.
28. Lehmann, OJ, ND Ebenezer, R Ekong, et al: Ocular developmental abnormalities and glaucoma associated with interstitial 6p25 duplications and deletions. Invest. Ophthalmol. Vis. Sci. 43 (2002), 1843-1849.
29. Tran, H, A Brunet, EC Griffith, et al: The many forks in FOXO's road. Sci. STKE 172 (2003), RE5.
30. Schmoll, D, KS Walker, DR Alessi, et al: Regulation of glucose-6-phosphatase gene expression by protein kinase βα and the forkhead transcription factor FKHR. Evidence for insulin response unit-dependent and -independent effects of insulin on promoter activity. J. Biol. Chem. 275 (2000), 36324-36333.
31. Nakae, J, T Kitamura, DL Silver, et al: The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. J. Clin. Invest. 108 (2001), 1359-1367.
32. Hall, RK, T Yamasaki, T Kucera, et al: Regulation of phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein-1 gene expression by insulin. The role of winged helix/forkhead proteins. J. Biol. Chem. 275 (2000), 30169-30175.
33. Yeagley, D, S Guo, T Unterman, et al: Gene- and activation-specific mechanisms for insulin inhibition of basal and glucocorticoid-induced insulin-like growth factor binding protein-1 and phosphoenolpyruvate carboxykinase transcription. Roles of forkhead and insulin response sequences. J. Biol. Chem. 276 (2001), 33705-33710.
34. Jünger, MA, F Rintelen, H Stocker, et al: The Drosophila Forkhead transcription factor FOXO mediates the reduction in cell number associated with reduced insulin signaling. J. Biol. 2 (2003), 20.
35. Furuyama, T, K Kitayama, Y Shimoda, et al: Abnormal angiogenesis in Foxo1 (Fkhr)-deficient mice. J. Biol. Chem. 279 (2004), 34741-34749.
36. Davis, KE, M Moldes, SR Farmer: The forkhead transcription factor FoxC2 inhibits white adipocyte differentiation. J. Biol. Chem. 279 (2004), 42453-42461.
37. Grønning, LM, A Cederberg, N Miura, et al: Insulin and TNFα induce expression of the forkhead transcription factor gene Foxc2 in 3T3-L1 adipocytes via P13K and ERK 1/2-dependent pathways. Mol. Endocrinol. 16 (2002), 873-883.
38. Kim, JK, HJ Kim, SY Park, et al: Adipocyte-specific overexpression of FOXC2 prevents diet-induced increases n intramuscular fatty acyl CoA and insulin resistance. Diabetes 54 (2005), 1657-1653.
39. Tso, P, JA Balint: Formation and transport of chylomicrons by enterocytes to the lymphatics. Am. J. Physiol. (Castro. Intest. Liver Physiol.) 250 (1986), G715-G726.
40. Sylven, C, B Borgstrom: Absorption and lymphatic transport of cholesterol in the rat. J. Lipid Res. 9 (1968), 596-601.
41. Wang, DQ, B Paigen, MC Carey: Genetic factors at the enterocyte level account for variations in intestinal cholesterol absorption efficiency among inbred strains of mice. J. Lipid Res. 42 (2001), 1820-1830.
42. Rosen, E: The molecular control of adipogenesis, with special reference to lymphatic pathology. Ann. NY Acad. Sci. 979 (2002), 143-158.
43. Wigle JT, G Oliver: Prox1 function is required for the development of the murine lymphatic system. Cell 98 (1999), 769-78.
44. Ryan, TJ: Adipose tissue and lymphatic function: Is there more to this story especially for tropical diseases. Lymphology 39 (2006), 49-52.